GEODE CAPITAL MANAGEMENT, LLC - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 1 filers reported holding BELLEROPHON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$162,000
+44.6%
465,780
+100.0%
0.00%
Q3 2019$112,000
-19.4%
232,8900.0%0.00%
Q2 2019$139,000
-8.6%
232,8900.0%0.00%
Q1 2019$152,000
-59.1%
232,890
-50.0%
0.00%
Q4 2018$372,000
+67.6%
465,780
+126.3%
0.00%
Q3 2018$222,000
-55.4%
205,8630.0%0.00%
Q2 2018$498,000
+66.0%
205,863
+42.4%
0.00%
Q1 2018$300,000
-19.4%
144,5510.0%0.00%
Q4 2017$372,000
+81.5%
144,5510.0%0.00%
Q3 2017$205,000
+6.2%
144,5510.0%0.00%
Q2 2017$193,000
+1.6%
144,551
+12.9%
0.00%
Q1 2017$190,000127,9950.00%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Puissance Capital Management LP 8,298,755$21,410,00014.79%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 15,138,486$37,186,0002.82%
VHCP Management II, LLC 4,149,378$9,671,0002.32%
Boxer Capital, LLC 1,857,143$4,791,0000.88%
EAM Investors, LLC 237,975$614,0000.11%
Telemetry Investments, L.L.C. 79,421$205,0000.08%
Virtu Financial LLC 56,569$146,0000.01%
Renaissance Technologies 927,200$2,392,0000.00%
OXFORD ASSET MANAGEMENT LLP 30,348$79,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 23,000$59,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders